Bayer stock after-hours at EUR 48.90: minus 3.70 percent versus prior close
Published on 09/29/2026 at 19:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Bayer stock was at EUR 48.90 after-hours at 7:32 p.m. CEST on September 29, 2026, down 3.70 percent versus the EUR 50.78 prior close at Lang & Schwarz.
Bayer reports regulatory update
On September 28, 2026, Bayer said the U.S. Food and Drug Administration had accepted its supplemental new drug application and granted Priority Review for Lynkuet, or elinzanetant, for moderate to severe vasomotor symptoms in women receiving endocrine therapy for hormone receptor-positive breast cancer, according to Bayer.
Hybrid bond placement
Bayer AG said on September 23, 2026, that it had placed EUR 2.00 billion of hybrid bonds in two EUR 1.00 billion tranches. The six-year non-call tranche carries a 5.75 percent coupon, while the nine-year non-call tranche carries a 6.25 percent coupon, the company said in its release.
